Stella Diagnostics and Mayo Clinic to Present Data on the Utility of the STLA101 Test for Esophageal Cancer Staging at the 2022 AGA Digestive Disease Week Conference

Stock Information for Stella Diagnostics Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Stella Diagnostics Inc

Stella Diagnostics Announces Leadership Changes: Dr. Joe Abdo Assumes a New Role as Chief Scientific Officer, and Director David Seaburg is Appointed Chief Executive Officer
Stella Diagnostics Announces Data Presentation at the American Association for Cancer Research (AACR) Annual Meeting
Stella Diagnostics to Present at "Next Big Thing" Session at Society of American Gastroenterologists and Endoscopic Surgeons Annual Meeting
Stella Diagnostics Named 'Best Clinical Proteomics Solution' of 2021 by Biotech Breakthrough Awards
Stella Diagnostics CEO Discusses Competitive Advantage in Early Cancer Detection During Audio Interview with SmallCapVoice.com

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.